Molecular Diagnostics in 2020
Surveys from the Association for Molecular Pathology reveal the impact of the covid-19 pandemic on clinical labs and help to chart the course for 2021.
Read MorePosted by Laurie Bonner | Nov 23, 2020 | Covid 19, Lab Management, Molecular Diagnostics |
Surveys from the Association for Molecular Pathology reveal the impact of the covid-19 pandemic on clinical labs and help to chart the course for 2021.
Read MorePosted by Laurie Bonner | Nov 19, 2020 | Company News, Covid 19, Molecular Diagnostics |
Alaska, Florida, Louisiana, New Jersey, and Texas will receive the first shipments of the test used in the NBA bubble.
Read MorePosted by Laurie Bonner | Nov 4, 2020 | Covid 19, Immunoassay Reagents & test Kits |
Engineered recombinant antibodies offer advantages over serum-based controls.
Read MorePosted by Melanie Hamilton-Basich | Nov 2, 2020 | Cancer, Molecular Diagnostics |
A Medicare administrative contractor has established coverage of the StrataNGS test for patients with advanced stages (III or IV), recurrent, relapsed, refractory, and/or metastatic solid tumors.
Read MorePosted by Laurie Bonner | Nov 2, 2020 | Molecular Diagnostics, Sexually Transmitted Diseases |
A multiplex assay based on high-resolution melting technology accurately identified antimicrobial resistant determinants in Neisseria gonorrhoeae.
Read More